iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Trading 1.1% Higher

Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) were up 1.1% during mid-day trading on Tuesday . The company traded as high as $64.08 and last traded at $63.92. Approximately 16,032 shares traded hands during mid-day trading, a decline of 78% from the average daily volume of 71,795 shares. The stock had previously closed at $63.25.

iShares U.S. Pharmaceuticals ETF Price Performance

The stock has a market cap of $634.79 million, a PE ratio of 6.23 and a beta of 0.59. The business has a fifty day moving average of $66.77 and a 200 day moving average of $62.87.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of IHE. CX Institutional purchased a new position in iShares U.S. Pharmaceuticals ETF in the third quarter valued at about $300,000. Stratos Wealth Advisors LLC purchased a new position in iShares U.S. Pharmaceuticals ETF in the third quarter valued at about $330,000. Apexium Financial LP bought a new position in iShares U.S. Pharmaceuticals ETF during the 3rd quarter worth approximately $203,000. SteelPeak Wealth LLC bought a new position in iShares U.S. Pharmaceuticals ETF during the 3rd quarter worth approximately $208,000. Finally, NBC Securities Inc. bought a new position in iShares U.S. Pharmaceuticals ETF during the 3rd quarter worth approximately $38,000.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.